ATC Group: R01A Decongestants and other nasal preparations for topical use

The World Health Organization's ATC classification organizes medical drugs based on therapeutic properties, chemical composition, and anatomy. It helps make essential medicines readily available globally and is widely used in the pharmaceutical industry.

Position of R01A in the ATC hierarchy

Level Code Title
1 R Respiratory system
2 R01 Nasal preparations
3 R01A Decongestants and other nasal preparations for topical use

Group R01A contents

Code Title
R01AA Sympathomimetics, plain
R01AB Sympathomimetics, combinations excl. corticosteroids
R01AC Antiallergic agents, excl. corticosteroids
R01AD Corticosteroids
R01AX Other nasal preparations

Active ingredients in R01A

Active Ingredient Description
Antazoline

Antazoline is an antagonist of histamine H1 receptors. It selectively bind to but does not activate histamine H1 receptors, thereby blocking the actions of endogenous histamine, which subsequently leads to temporary relief of the negative symptoms brought on by histamine.

Azelastine

Azelastine, a phthalazinone derivative is classified as a potent long-acting anti-allergic compound with selective H1 antagonist properties. An additional anti-inflammatory effect could be detected after topical ocular administration. Data from in vivo (pre-clinical) and in vitro studies show that azelastine inhibits the synthesis or release of the chemical mediators known to be involved in early and late stage allergic reactions e.g. leukotriene, histamine, PAF and serotonin.

Beclometasone

Beclometasone is a pro-drug with weak glucocorticoid receptor binding affinity. It is extensively hydrolysed via esterase enzymes to the active metabolite beclometasone-17-monopropionate (B-17-MP), which has potent topical anti-inflammatory activity.

Betamethasone

Betamethasone is a glucocorticoid which is about eight to ten times as active as prednisolone on a weight-for-weight basis. Betamethasone has anti-inflammatory, antipruritic, and vasoconstrictive properties.

Budesonide

Budesonide is a glucocorticosteroid with a high local anti-inflammatory effect. At doses clinically equivalent to systemically acting glucocorticosteroids, budesonide gives significantly less HPA axis suppression and has a lower impact on inflammatory markers.

Ciclesonide

Ciclesonide exhibits low binding affinity to the glucocorticoid-receptor. Once orally inhaled, ciclesonide is enzymatically converted in the lungs to the principal metabolite (C21-des-methylpropionyl-ciclesonide) which has a pronounced anti-inflammatory activity and is thus considered as the active metabolite.

Cromoglicic acid

Sodium cromoglicate (Cromoglicic acid) inhibits the activation of many of the cell types involved in the development and progression of asthma. Thus, sodium cromoglicate inhibits the release of inflammatory mediators including cytokines from mast cells and reduces the chemotactic activity of eosinophils and neutrophils.

Dexamethasone

Dexamethasone is a synthetic glucocorticoid; it combines high anti-inflammatory effects with low mineralocorticoid activity. It has an approximately 7 times greater anti-inflammatory potency than prednisolone, another commonly prescribed corticosteroid. At high doses it reduces the immune response.

Ephedrine

Ephedrine is a sympathomimetic amine acting directly on the alpha and beta receptors and indirectly by increasing the release of noradrenaline by the sympathetic nerve endings. As with any sympathomimetic agent, ephedrine stimulates the central nervous system, the cardiovascular system, the respiratory system, and the sphincters of the digestive and urinary systems.

Epinephrine

Epinephrine is a direct acting sympathomimetic agent, which exerts effects on both α and β adrenoceptors. It has more pronounced effects on β than on α adrenoceptors, although α effects prevail at high doses. The effects of adrenaline include increased rate and force of cardiac contraction, cutaneous vasoconstriction and broncho-dilatation.

Fenoxazoline
Flunisolide

Flunisolide is a glucocorticoid and it is several hundred times more potent than the cortisol standard. The principal mechanism of action of flunisolide is to activate glucocorticoid receptors, meaning it has an anti-inflammatory action. It is used for the treatment of allergic rhinitis.

Fluticasone

Fluticasone has anti-inflammatory and vasoconstrictive features. Fluticasone given by inhalation at recommended doses has a potent glucocorticoid anti-inflammatory action within the lungs, resulting in a reduction of both symptoms and exacerbations of asthma, with a lower incidence and severity of adverse effects than those observed when corticosteroids are administered systemically.

Fluticasone furoate

Fluticasone furoate is a synthetic trifluorinated corticosteroid that possesses a very high affinity for the glucocorticoid receptor and has a potent anti-inflammatory action.

Framycetin
Hexamidine
Hyaluronate sodium
Ipratropium

Ipratropium is a quaternary ammonium compound with anticholinergic (parasympatholytic) properties. Ipratropium appears to inhibit vagally mediated reflexes by antagonising the action of acetylcholine, the transmitter agent released from the vagus nerve. Anticholinergics prevent the increase in intracellular concentration of Ca++, which is caused by interaction of acetylcholine with the muscarinic receptor on bronchial smooth muscle. Ca++ release is mediated by the second messenger system consisting of IP3 (inositol triphosphate) and DAG (diacylglycerol).

Levocabastine

Levocabastine is a potent, fast-acting and highly selective histamine H1-antagonist with a sustained duration of action.

Mometasone

Mometasone is a topical glucocorticoid with local anti-inflammatory properties. It is likely that much of the mechanism for the effects of mometasone lies in its ability to inhibit the release of mediators of the inflammatory cascade.

Mupirocin

Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally.

Naphazoline

Naphazoline is a sympathomimetic amine with pronounced alpha adrenergic activity and as a consequence has vasoconstrictor activity.

Nedocromil

Nedocromil is a non-steroidal agent, which has anti-inflammatory properties when administered topically in the lung. In the treatment of bronchial asthma, nedocromil sodium reduces bronchospasm, cough and bronchial hyperreactivity and improves objective measurements of lung function.

Olopatadine

Olopatadine is a potent selective antiallergic/antihistaminic agent that exerts its effects through multiple distinct mechanisms of action.

Oxymetazoline

Oximetazoline is an imidazoline derivative. It exhibits sympathomimetic activity and specifically stimulates the α-adrenergic receptors of the sympathetic system. When administered topically to the nose it causes vasoconstriction of the expansed arterioles of the mucosal nose and a concurrent reduction in blood flow. It also reduces the hypersecretion of the nasal mucosa, ultimately contributing to the decongestion of the nasal mucosa.

Phenylephrine

Phenylephrine is a sympathomimetic agent with mainly direct effects on adrenergic receptors. It has predominantly alpha adrenergic activity and is without stimulating effects on the central nervous system. The sympathomimetic effect of phenylephrine produces vasoconstriction which in turn relieves nasal congestion.

Prednisolone

Prednisolone is a glucocorticoid which has anti-inflammatory activity. Naturally occurring glucocorticoids (hydrocortisone and cortisone), which also have salt-retaining properties, are used as replacement therapy in adrenocortical deficiency states. Their synthetic analogs are primarily used for their potent anti-inflammatory effects in disorders of many organ systems.

Ritiometan
Tetryzoline

Tetryzoline is an alpha adrenergic receptor agonist, which is used in form of nasal solution or spray for decongestion of nasal and nasopharyngeal mucosa.

Thonzylamine
Tixocortol

Tixocortol is a 21-thiol derivative of hydrocortisone classified as a class A corticosteroid. It is a synthetic steroid with topical anti-inflammatory properties without the systemic glucocorticoid and mineralocorticoid activities and toxicity.

Tramazoline

Tramazoline is an α-sympathomimetic agent with local action, which mainly causes vasoconstriction and therefore immediately reduces mucosal edema.

Triamcinolone

Triamcinolone acetonide is a more potent derivative of triamcinolone and is approximately 8 times more potent than prednisone. Although the precise mechanism of corticosteroid anti-allergic action is unknown, corticosteroids are very effective in the treatment of allergic diseases in man. Also, local injections are thought to have an anti-inflammatory effect.

Tuaminoheptane
Xylometazoline

Xylometazoline acts directly on α-adrenoreceptors but does not act on β-receptors. When used topically as a nasal decongestant, xylometazoline acts rapidly and provides long-lasting relief. Onset of action is within minutes, the decongestant effect being prolonged and lasting for up to 10 hours.

Related product monographs

Title Information Source Document Type  
ATROVENT HFA Inhalation aerosol, metered FDA, National Drug Code (US) MPI, US: SPL/PLR
ATROVENT Nebuliser solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
AVAMYS Nasal spray, suspension European Medicines Agency (EU) MPI, EU: SmPC
BACTROBAN 2% Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BACTROBAN Nasal ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BECONASE Aqueous suspension for intranasal inhalation Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDESONIDE 64 Aqueous Nasal Spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
BUDESONIDE Nebuliser Suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
CLENIL FORTE SPRAY Pressurised inhalation solution Υπουργείο Υγείας (CY) MPI, EU: SmPC
CLENIL Pressurised inhalation solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
DECADRON Oral solution FDA, National Drug Code (US) MPI, US: SPL/Old
EPHEDRINE 1.0% Nasal drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPHEDRINE HYDROCHLORIDE Solution for injection Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
EPHEDRINE HYDROCHLORIDE Tablet Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLIXONASE Nasal drops Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLIXONASE Nasal spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLIXOTIDE EVOHALER Pressurised inhalation, suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
FLONASE ALLERGY RELIEF Aqueous nasal spray Health Products and Food Branch (CA) MPI, CA: SPM
IPRAVENT Pressurised inhalation, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MOMETASONE FUROATE Cream Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
MURIPOCIN 2% w/w Ointment Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NALCROM Capsule Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NASACORT Nasal Spray suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
NASOBEC Nasal spray, suspension Health Products Regulatory Authority (IE) MPI, EU: SmPC
NASONEX Nasal spray FDA, National Drug Code (US) MPI, US: SPL/PLR
NASONEX Nasal Spray, Suspension Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
OMNARIS Nasal spray FDA, National Drug Code (US) MPI, US: SPL/PLR
OTRIVIN ADULT Menthol Nasal spray, solution Health Products Regulatory Authority (IE) MPI, EU: SmPC
OTRIVINE ADULT Nasal spray, solution Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
PULMICORT TURBOHALER 100 Breath-actuated metered dose powder inhaler Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RHINOLAST Nasal spray Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC
RYALTRIS Nasal spray, suspension Health Products Regulatory Authority (IE) MPI, EU: SmPC
UTABON ADULTS Nasal spray, solution Medicines Authority (MT) MPI, EU: SmPC
UTABON PEDIATRIC Nasal drops, solution Medicines Authority (MT) MPI, EU: SmPC
Vividrin Eye Drops 2% sodium cromoglicate Medicines & Healthcare Products Regulatory Agency (GB) MPI, EU: SmPC